DIALYSIS · CCN 392787

DaVita University City Dialysis

Philadelphia, PA 19104

DialysisProfitDaVita
$8.4M
TOTAL REVENUE
7.6%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$8.4M
Total costs
$7.7M
Operating income (rev − costs)
$632K
Operating margin
7.6%
Total charges
$8.7M
Total treatments
19,652
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.0570—
Fistula Rate
DFC_FISTULA_RATE
57.6106—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.2230—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
2——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
130.9126—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.31——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
17106—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
11.9508—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
39.7142—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
27.280—
Standardized ED Visits Ratio
DFC_SEDR
0.7369—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
40.958—